PT2413899T - Anestésico dentário contendo tetracaína e um vasoconstritor para administração intranasal - Google Patents

Anestésico dentário contendo tetracaína e um vasoconstritor para administração intranasal

Info

Publication number
PT2413899T
PT2413899T PT107141194T PT10714119T PT2413899T PT 2413899 T PT2413899 T PT 2413899T PT 107141194 T PT107141194 T PT 107141194T PT 10714119 T PT10714119 T PT 10714119T PT 2413899 T PT2413899 T PT 2413899T
Authority
PT
Portugal
Prior art keywords
vasoconstrictor
tetracaine
intranasal administration
dental anesthetic
anesthetic
Prior art date
Application number
PT107141194T
Other languages
English (en)
Portuguese (pt)
Original Assignee
St Renatus Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Renatus Llc filed Critical St Renatus Llc
Publication of PT2413899T publication Critical patent/PT2413899T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M19/00—Local anaesthesia; Hypothermia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT107141194T 2009-04-03 2010-04-02 Anestésico dentário contendo tetracaína e um vasoconstritor para administração intranasal PT2413899T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16668009P 2009-04-03 2009-04-03

Publications (1)

Publication Number Publication Date
PT2413899T true PT2413899T (pt) 2021-03-30

Family

ID=42164462

Family Applications (1)

Application Number Title Priority Date Filing Date
PT107141194T PT2413899T (pt) 2009-04-03 2010-04-02 Anestésico dentário contendo tetracaína e um vasoconstritor para administração intranasal

Country Status (18)

Country Link
US (7) US8580282B2 (enExample)
EP (1) EP2413899B1 (enExample)
JP (3) JP5788864B2 (enExample)
KR (2) KR101747979B1 (enExample)
CN (2) CN102421416B (enExample)
AU (2) AU2010232995C1 (enExample)
BR (1) BRPI1010303A2 (enExample)
CA (1) CA2757032C (enExample)
DK (1) DK2413899T3 (enExample)
EA (1) EA024184B1 (enExample)
ES (1) ES2861064T3 (enExample)
IL (1) IL215489A0 (enExample)
MX (1) MX2011010445A (enExample)
NZ (2) NZ595376A (enExample)
PL (1) PL2413899T3 (enExample)
PT (1) PT2413899T (enExample)
WO (1) WO2010114622A1 (enExample)
ZA (2) ZA201107011B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5788864B2 (ja) 2009-04-03 2015-10-07 セイント レナタス， エルエルシー 鼻腔内投与用のテトラカインおよび血管収縮薬を含む歯科用麻酔剤
NZ629475A (en) 2012-09-28 2017-03-31 St Renatus Llc Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines
WO2015103450A1 (en) * 2014-01-01 2015-07-09 Real Time Imaging Technologies, Llc Improved local anesthetic solution for dental and/or contrast media use
AU2015277272A1 (en) * 2014-06-16 2017-01-12 Loewi LLC Methods of anesthetizing nerve tissue in the trigeminal nerve pathway and medical uses thereof
EA201791448A1 (ru) * 2014-12-23 2017-11-30 СТ. РЕНАТУС, ЭлЭлСи Анестетик на основе тетракаина
WO2016115117A1 (en) 2015-01-12 2016-07-21 Real Time Imaging Technologies, Llc Low-dose x-ray imaging system
US10039830B2 (en) * 2016-03-04 2018-08-07 Cetylite Industries, Inc. Topical anesthetic composition
WO2017210390A1 (en) * 2016-06-01 2017-12-07 St. Renatus, Llc Intranasal dental anesthetic
CA3122363A1 (en) 2018-12-19 2020-06-25 Nortic Holdings Inc. Therapeutic composition of intranasal lidocaine
CN111494310A (zh) * 2020-04-29 2020-08-07 周晓玲 一种局部麻醉药物的制备及使用方法
EP4648760A1 (en) * 2023-01-13 2025-11-19 Smilanich, Michael D. Composition for local anesthesia and uses thereof
GB2628149A (en) * 2023-03-16 2024-09-18 Lee Nathaniel Wurie Nasal spray for performing sphenopalatine ganglion block

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3832460A (en) * 1971-03-19 1974-08-27 C Kosti Anesthetic-vasoconstrictor-antihistamine composition for the treatment of hypertrophied oral tissue
US5209724A (en) 1988-04-11 1993-05-11 Dhaliwal Avtar S Composite anesthetic article and method of use
AU4673993A (en) 1992-07-28 1994-02-14 Procter & Gamble Company, The Pharmaceutical composition for topical use containing a crosslinked cationic polymer and an alkoxylated ether
US5854269A (en) 1993-11-19 1998-12-29 Schering-Plough Healthcare Products, Inc. Nasal spray compositions
US5585398A (en) 1994-07-15 1996-12-17 Ernst; Amy A. Topical anesthetic comprising lidocaine, adrenaline, and tetracaine, and its method of use
US6075059A (en) 1999-02-24 2000-06-13 The Ohio State University Compositions for dental anesthesia
US20040131665A1 (en) * 1999-10-22 2004-07-08 Wepfer Scott T. Topical anesthetic formulation
US6413499B1 (en) * 2000-01-06 2002-07-02 Bryan M. Clay Methods and kits for maxillary dental anesthesia by means of a nasal deliverable anesthetic
US20040045546A1 (en) 2002-09-05 2004-03-11 Peirce Management, Llc Pharmaceutical delivery system for oral inhalation through nebulization consisting of inert substrate impregnated with substance (S) to be solubilized or suspended prior to use
JP4591746B2 (ja) * 2002-12-03 2010-12-01 大正製薬株式会社 難溶性抗ウイルス成分含有水溶性外用剤組成物
ES2223277B1 (es) * 2003-06-19 2006-03-01 Fernando Bouffard Fita Composicion anestesica para administracion topica.
WO2005065696A1 (en) 2004-01-01 2005-07-21 Panacea Biotec Ltd. Pharmaceutical compositions comprising an extract of euphorbia prostrata
US20060052305A1 (en) * 2004-05-10 2006-03-09 Nastech Pharmaceutical Company Inc. Method of treating osteoporosis using intranasal parathyroid hormone
WO2007050543A2 (en) 2005-10-24 2007-05-03 Collegium Pharmaceutical, Inc. Topical pharmaceutical foam composition
US9252862B2 (en) 2008-09-17 2016-02-02 Qualcomm Incorporated MIMO preamble for initial access with an unknown number of transmit antennas
JP5788864B2 (ja) * 2009-04-03 2015-10-07 セイント レナタス， エルエルシー 鼻腔内投与用のテトラカインおよび血管収縮薬を含む歯科用麻酔剤

Also Published As

Publication number Publication date
AU2015242984B2 (en) 2017-09-14
CN102421416B (zh) 2014-05-28
AU2010232995C1 (en) 2016-01-28
EA201171215A1 (ru) 2012-07-30
AU2010232995A1 (en) 2011-10-20
US10420750B2 (en) 2019-09-24
US20170326112A1 (en) 2017-11-16
CA2757032C (en) 2022-06-07
US20170326111A1 (en) 2017-11-16
IL215489A0 (en) 2011-12-29
JP2015034167A (ja) 2015-02-19
CN102421416A (zh) 2012-04-18
KR20120042729A (ko) 2012-05-03
US20170319547A1 (en) 2017-11-09
US20160184269A1 (en) 2016-06-30
US9308191B2 (en) 2016-04-12
JP5788864B2 (ja) 2015-10-07
US20140234421A1 (en) 2014-08-21
KR20170026639A (ko) 2017-03-08
CN103932973B (zh) 2017-08-11
NZ595376A (en) 2013-09-27
AU2010232995B2 (en) 2015-07-16
PL2413899T3 (pl) 2021-09-20
BRPI1010303A2 (pt) 2016-03-15
EA024184B1 (ru) 2016-08-31
KR101747979B1 (ko) 2017-06-15
CN103932973A (zh) 2014-07-23
CA2757032A1 (en) 2010-10-07
US10456377B2 (en) 2019-10-29
ZA201107011B (en) 2014-03-26
EP2413899B1 (en) 2021-01-27
US20120039960A1 (en) 2012-02-16
JP2012522783A (ja) 2012-09-27
NZ612063A (en) 2015-02-27
WO2010114622A1 (en) 2010-10-07
ZA201309321B (en) 2016-07-27
DK2413899T3 (da) 2021-04-19
AU2015242984A1 (en) 2015-11-05
US8580282B2 (en) 2013-11-12
US20200268715A1 (en) 2020-08-27
MX2011010445A (es) 2012-01-19
JP2017031226A (ja) 2017-02-09
US9855247B2 (en) 2018-01-02
ES2861064T3 (es) 2021-10-05
EP2413899A1 (en) 2012-02-08

Similar Documents

Publication Publication Date Title
ZA201107011B (en) Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration
EP2349428A4 (en) NASAL BITS FOR A PATIENT INTERFACE
GB2509641B (en) Patient interface and aspects thereof
GB2494493B (en) Patient interface and aspects thereof
ZA201201975B (en) Improved device and method for delivery of a medicament
NO2017033I2 (no) baricitinib og farmasøytisk akseptable salter derav
EP2242527A4 (en) DEVICES AND METHODS FOR ADMINISTERING A THERAPEUTIC AGENT THROUGH PNEUMOSTOMY
ZA201203938B (en) Portion capsule and use of a portion capsule
PT2525737T (pt) Pivô para um implante dentário e combinação de pivô e implante
EP2370136A4 (en) INHALATIVE RELEASE PROCEDURES AND DEVICES
SI2505586T1 (sl) Indolna spojina in njena farmacevtska uporaba
IL222919A (en) Alcohol-resistant oral form
IL212074A0 (en) Inhalation device and method of dispensing medicament
ZA201008589B (en) Medicament dispenser and method
IL207586A0 (en) A fibrin based therapeutic preparation and use thereof
EP2431365A4 (en) AZETIDINE COMPOUND AND ITS MEDICAL USE
EP2501411A4 (en) PROCESS FOR IMPROVED ORAL ADMINISTRATION
IL245577A0 (en) Dose unit of efdanosone
GB0822124D0 (en) Oral dosage form
AP2788A (en) Simalikalactone E and use thereof as a medicament
HK1165296A (en) Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration
IL208994A0 (en) Oral/nasal cannula
GB0900990D0 (en) Dental floss and tape
GB0815510D0 (en) Devices and methods for oral fluid delivery
GB0917118D0 (en) A capsule for oral administration